कृपया अन्य खोज का प्रयास करें
Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its lead products comprise Tutivia, a post-transplant test focused on acute rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company also develops Protega, a peripheral blood-based test that aims to predict the risk of fibrosis and long-term graft failure. Verici Dx plc was incorporated in 2020 and is based in Penarth, the United Kingdom.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Philip O'Connell | - | - | Member of Advisory Board |
Ian James Carruthers | 72 | 2020 | Senior Independent Non-Executive Director |
Sara Barrington | 55 | 2020 | CEO & Executive Director |
Anthony Dorling | - | - | Member of Advisory Board |
Richard Formica | - | - | Member of Advisory Board |
David M. Rothstein | - | - | Member of Advisory Board |
James R. McCullough | 55 | 2020 | Independent Non-Executive Director |
Emilio D. Poggio | - | - | Member of Advisory Board |
Julian Huw Baines | 58 | 2020 | Independent Non-Executive Chairman |
Roslyn B. Mannon | - | - | Member of Advisory Board |
Lorenzo Giovanni Gallon | 57 | 2021 | Non-Executive Director & Chair of Science Advisory Board |
Erik K. Lium | 54 | 2020 | Independent Non-Executive Director |
Weiija Zhang | - | - | Member of Advisory Board |
Peter Nickerson | - | - | Member of Advisory Board |
Kathryn Wood | - | - | Member of Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है